Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.

Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

Researchers developed a DNA barcoding assay to measure nanoparticle cargo escape in living organisms, enabling a new class of lipid nanoparticles for more efficient gene editing.

DNA strands on tiny beads hide and reveal encrypted messages through programmable fluorescence patterns read by flow cytometry.

A single week in late October 2025 produced a wave of new species discoveries across five countries, all connected by camouflage strategies so effective that the animals evaded scientific detection ...

Australian scientists have discovered that DNA barcoding can be used to track cancer cells in solid and liquid biopsies, empowering future research into more reliable breast cancer diagnosis and ...

The Netherlands has launched an ambitious national program to map and barcode every known plant, animal, and fungal species in the country, aiming to create one of the most comprehensive DNA libraries ...

GeneParliamentID (GPID) is a pipeline for sample identification using hundreds or thousands of genes, such as those generated using targeted sequence capture. GeneParliamentID integrates species ...

A groundbreaking gene-editing method from UT Austin is changing the game for treating complex genetic diseases like cystic fibrosis, hemophilia, and Tay Sachs. Using retrons—DNA tools borrowed from ...